<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/98A16AA1-0D1A-47AD-BDB7-0898EDD37783"><gtr:id>98A16AA1-0D1A-47AD-BDB7-0898EDD37783</gtr:id><gtr:name>Faculty of Engineering</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Infectious and Tropical Diseases</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/98A16AA1-0D1A-47AD-BDB7-0898EDD37783"><gtr:id>98A16AA1-0D1A-47AD-BDB7-0898EDD37783</gtr:id><gtr:name>Faculty of Engineering</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8"><gtr:id>3DF2F8DD-33A5-44A1-81D7-347A6C2FBDC8</gtr:id><gtr:name>Stanford University</gtr:name><gtr:address><gtr:line1>450 Serra Mall</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/367A7F0A-57ED-4E94-96AE-BC297C2CDAFE"><gtr:id>367A7F0A-57ED-4E94-96AE-BC297C2CDAFE</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>M</gtr:otherNames><gtr:surname>Davis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/E0EF8151-9297-4E9C-869E-50B011AE78BD"><gtr:id>E0EF8151-9297-4E9C-869E-50B011AE78BD</gtr:id><gtr:firstName>Eleanor</gtr:firstName><gtr:surname>Riley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0400225"><gtr:id>881EDDA8-4BEA-4566-90F4-0BD0A589FD8D</gtr:id><gtr:title>Recognition of Plasmodium falciparum-infected red blood cells by human Natural Killer cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400225</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2004-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>204400</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:department>Department of Microbiology and Immunology</gtr:department><gtr:description>Stanford University</gtr:description><gtr:id>81A545C0-5D09-4708-88F3-24B3DF444209</gtr:id><gtr:impact>4 published papers 14607943 17694054 19411600 19414796</gtr:impact><gtr:partnerContribution>Genetic analysis of diversity in human KIR genes and their relationship to NK cell function
Access to KIR genotyping technologies and KIR diversity data for our study participants
Access to CyTOF technology</gtr:partnerContribution><gtr:piContribution>We carry out phenotypic analysis of NK cells to various infectious stimuli.
We provide cells for CyTOF analysis and DNA for genetic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Stanford University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Stanford University</gtr:description><gtr:id>3464679F-F2E7-42E4-AD15-FB803E3949A9</gtr:id><gtr:impact>4 published papers 14607943 17694054 19411600 19414796</gtr:impact><gtr:partnerContribution>Genetic analysis of diversity in human KIR genes and their relationship to NK cell function
Access to KIR genotyping technologies and KIR diversity data for our study participants
Access to CyTOF technology</gtr:partnerContribution><gtr:piContribution>We carry out phenotypic analysis of NK cells to various infectious stimuli.
We provide cells for CyTOF analysis and DNA for genetic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Engineering</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Bioengineering</gtr:department><gtr:description>Imperial College</gtr:description><gtr:id>4686FC9A-BB26-4E4E-8F45-CADFBA06DE27</gtr:id><gtr:impact>We have published 3 papers (see publications list) and another is currently under review.</gtr:impact><gtr:partnerContribution>Access to NK cell cloning and imaging technologies</gtr:partnerContribution><gtr:piContribution>We carried out the pathoegn-related aspects of exploring NK cell Biology. Prof Dan Davis at Imperial carried out the NK cell cloning and microspcopy aspects of the projects.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A99C1EE-5235-4015-AE39-4F2B6615B912"><gtr:id>0A99C1EE-5235-4015-AE39-4F2B6615B912</gtr:id><gtr:title>Synergy between Common ? Chain Family Cytokines and IL-18 Potentiates Innate and Adaptive Pathways of NK Cell Activation.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcab03e446c5cb8f40ff33d710919480"><gtr:id>fcab03e446c5cb8f40ff33d710919480</gtr:id><gtr:otherNames>Nielsen CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0979BB7F-D667-4DB8-9BA1-FBA93D61C507"><gtr:id>0979BB7F-D667-4DB8-9BA1-FBA93D61C507</gtr:id><gtr:title>Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54817bccf0cc7f30db605bb92b765d2c"><gtr:id>54817bccf0cc7f30db605bb92b765d2c</gtr:id><gtr:otherNames>Horowitz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/22079135-F5EB-42D6-8206-10CEBC0A8C62"><gtr:id>22079135-F5EB-42D6-8206-10CEBC0A8C62</gtr:id><gtr:title>Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3ead8fe6797bd4257fb21f7afec954b"><gtr:id>a3ead8fe6797bd4257fb21f7afec954b</gtr:id><gtr:otherNames>Goodier MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D87D05B-8693-46A5-B199-86C1B4F30187"><gtr:id>0D87D05B-8693-46A5-B199-86C1B4F30187</gtr:id><gtr:title>Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcab03e446c5cb8f40ff33d710919480"><gtr:id>fcab03e446c5cb8f40ff33d710919480</gtr:id><gtr:otherNames>Nielsen CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA14509F-EF5B-4B26-956E-0BCD9A1C213C"><gtr:id>BA14509F-EF5B-4B26-956E-0BCD9A1C213C</gtr:id><gtr:title>IL-18-induced expression of high-affinity IL-2R on murine NK cells is essential for NK-cell IFN-? production during murine Plasmodium yoelii infection.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27cb1d45499e39ae5eaa8757209fada3"><gtr:id>27cb1d45499e39ae5eaa8757209fada3</gtr:id><gtr:otherNames>Stegmann KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17040406-62FA-4741-A778-6A24E451D27E"><gtr:id>17040406-62FA-4741-A778-6A24E451D27E</gtr:id><gtr:title>Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba628a903290c55229e23b5aff5ffe84"><gtr:id>ba628a903290c55229e23b5aff5ffe84</gtr:id><gtr:otherNames>White MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6B98B7D9-BBE4-4651-A728-20368D215D9C"><gtr:id>6B98B7D9-BBE4-4651-A728-20368D215D9C</gtr:id><gtr:title>Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fcab03e446c5cb8f40ff33d710919480"><gtr:id>fcab03e446c5cb8f40ff33d710919480</gtr:id><gtr:otherNames>Nielsen CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/825DA586-EB97-4DB1-ADC2-DD7240E48866"><gtr:id>825DA586-EB97-4DB1-ADC2-DD7240E48866</gtr:id><gtr:title>Calorie Restriction Attenuates Terminal Differentiation of Immune Cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba628a903290c55229e23b5aff5ffe84"><gtr:id>ba628a903290c55229e23b5aff5ffe84</gtr:id><gtr:otherNames>White MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1292013B-FD67-47AA-BF60-B84FAE5F0BB9"><gtr:id>1292013B-FD67-47AA-BF60-B84FAE5F0BB9</gtr:id><gtr:title>Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3ead8fe6797bd4257fb21f7afec954b"><gtr:id>a3ead8fe6797bd4257fb21f7afec954b</gtr:id><gtr:otherNames>Goodier MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/802FBD6B-AC1A-49BD-8162-57C365662CFA"><gtr:id>802FBD6B-AC1A-49BD-8162-57C365662CFA</gtr:id><gtr:title>Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba628a903290c55229e23b5aff5ffe84"><gtr:id>ba628a903290c55229e23b5aff5ffe84</gtr:id><gtr:otherNames>White MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EEB143F7-577F-4887-91D6-3CF489812B86"><gtr:id>EEB143F7-577F-4887-91D6-3CF489812B86</gtr:id><gtr:title>Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3ead8fe6797bd4257fb21f7afec954b"><gtr:id>a3ead8fe6797bd4257fb21f7afec954b</gtr:id><gtr:otherNames>Goodier MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFBC8DFC-F9AE-47ED-B647-13A6798F4192"><gtr:id>EFBC8DFC-F9AE-47ED-B647-13A6798F4192</gtr:id><gtr:title>Activation of human NK cells by Plasmodium-infected red blood cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/54817bccf0cc7f30db605bb92b765d2c"><gtr:id>54817bccf0cc7f30db605bb92b765d2c</gtr:id><gtr:otherNames>Horowitz A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400225</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>